Thomas K. Equels - Nov 30, 2023 Form 4 Insider Report for AIM ImmunoTech Inc. (AIM)

Role
CEO & President, Director
Signature
/s/ Thomas K Equels
Stock symbol
AIM
Transactions as of
Nov 30, 2023
Transactions value $
$0
Form type
4
Date filed
3/27/2024, 01:52 PM
Previous filing
Nov 27, 2023
Next filing
Mar 18, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AIM Options Award $0 +300K $0.00 300K Nov 30, 2023 Common Stock 300K $0.47 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.